We are live on
!
Find out more
HCC
Hirtle Callaghan & Co Portfolio holdings
AUM
$2.92B
1-Year Est. Return
17.65%
This Fund
S&P 500
This Quarter
Est. Return
+2.24%
1 Year Est. Return
+17.65%
3 Year Est. Return
+46.66%
5 Year Est. Return
+38.61%
10 Year Est. Return
+120.72%
AUM
$2.94B
AUM Growth
+$92.3M
(+3.2%)
Cap. Flow
+$7.04M
Cap. Flow
% of AUM
0.24%
Top 10 Holdings %
Top 10 Hldgs %
77.28%
Holding
112
New
11
Increased
25
Reduced
29
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$12.2M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.69M |
| 3 |
Apple
AAPL
|
+$6.09M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$6.01M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$3.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17.5M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$6.11M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$4.77M |
| 4 |
Vanguard Russell 1000 ETF
VONE
|
+$3.61M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$2.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 0.94% |
| 2 | Consumer Staples | 0.86% |
| 3 | Financials | 0.52% |
| 4 | Technology | 0.44% |
| 5 | Healthcare | 0.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Tesla
TSLA
$1.43T
| $321K | 0.01% |
+714
| New | +$317K |
|
102
iShares MSCI EAFE Value ETF
EFV
$26B
| $316K | 0.01% |
4,428
| – | – |
|
103
Accenture
ACN
$87.9B
| $314K | 0.01% |
1,169
-108
| -8% | -$27.4K |
|
104
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.6B
| $306K | 0.01% |
4,926
-160
| -3% | -$9.62K |
|
105
Amazon
AMZN
$2.66T
| $301K | 0.01% |
+1,302
| New | +$298K |
|
106
iShares Core Dividend Growth ETF
DGRO
$42.1B
| $269K | 0.01% |
3,869
| – | – |
|
107
ExxonMobil
XOM
$611B
| $266K | 0.01% |
+2,214
| New | +$257K |
|
108
ConocoPhillips
COP
$140B
| $259K | 0.01% |
2,766
+43
| +2% | +$3.89K |
|
109
Invesco QQQ Trust
QQQ
$466B
| $249K | 0.01% |
406
+35
| +9% | +$21.5K |
|
110
GoodRx Holdings
GDRX
$1.06B
| $49.5K | ﹤0.01% |
18,261
+6,869
| +60% | +$22.6K |
|
111
Silgan Holdings
SLGN
$4.99B
| – | – |
-10,000
| Closed | -$430K |
|
112
Vanguard Russell 3000 ETF
VTHR
$4.66B
| – | – |
-2,078
| Closed | -$612K |
|
Similar funds
CCPM
SCM
MYLI
CCM
BAM
CWM
NRCM
FNT
Hirtle Callaghan & Co's Q4 2025 Portfolio in Review
As of Q4 2025, Hirtle Callaghan & Co held 112 positions worth $2.94B, up 3.2% from $2.84B the previous quarter. Its ten largest holdings account for 77% of the portfolio.
Hirtle Callaghan & Co's Q4 2025 filing shows 11 new, 25 increased, 29 reduced and 2 closed positions. Its largest new stake was Apple: 22,668 shares worth $6.16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $17.5M.
By sector, the portfolio is most concentrated in Communication Services at 0.94% of assets, up from 0.92% a quarter earlier, followed by Consumer Staples and Financials.
- Hirtle Callaghan & Co's largest Q4 2025 buy was Apple: 22,668 shares worth $6.16M.
- Hirtle Callaghan & Co added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $12.2M increase.
- Hirtle Callaghan & Co's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $17.5M.
- Hirtle Callaghan & Co fully exited Vanguard Russell 3000 ETF in Q4 2025, selling an estimated $612K.
- Hirtle Callaghan & Co's ten largest holdings make up 77% of its $2.94B portfolio in Q4 2025.
- Hirtle Callaghan & Co opened 11 new positions and closed 2 in Q4 2025.
- Hirtle Callaghan & Co's portfolio value rose 3.2% quarter-over-quarter to $2.94B.
Based on Hirtle Callaghan & Co's 13F filing for Q4 2025, filed 4 Feb 2026.